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Abstract
Standard sample size calculation formulas for Stepped Wedge Cluster Random-
ized Trials (SW-CRTs) assume that cluster sizes are equal. When cluster sizes vary
substantially, ignoring this variation may lead to an under-powered study. We in-
vestigate the relative efficiency of a SW-CRT with varying cluster sizes to equal
cluster sizes, and derive variance estimators for the intervention effect that account
for this variation under the assumption of a mixed effects model; a commonly-
used approach for analyzing data from cluster randomized trials. When cluster
sizes vary, the power of a SW-CRT depends on the order in which clusters receive
the intervention, which is determined through randomization. We first derive a
variance formula that corresponds to any particular realization of the randomized
sequence and propose efficient algorithms to identify upper and lower bounds of
the power. We then obtain an “expected” power based on a first-order approx-
imation to the variance formula, where the expectation is taken with respect to
all possible randomization sequences. Finally, we provide a variance formula for
more general settings where only the mean and coefficient of variation of cluster
sizes, instead of exact cluster sizes, are known in the design stage. We evaluate
our methods through simulations and illustrate that the power of a SW-CRT de-
creases as the variation in cluster sizes increases, and the impact is largest when
the number of clusters is small.
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Summary: Standard sample size calculation formulas for Stepped Wedge Cluster Randomized Trials (SW-CRTs)
assume that cluster sizes are equal. When cluster sizes vary substantially, ignoring this variation may lead to an under-
powered study. We investigate the relative efficiency of a SW-CRT with varying cluster sizes to equal cluster sizes,
and derive variance estimators for the intervention effect that account for this variation under the assumption of a
mixed effects model; a commonly-used approach for analyzing data from cluster randomized trials. When cluster sizes
vary, the power of a SW-CRT depends on the order in which clusters receive the intervention, which is determined
through randomization. We first derive a variance formula that corresponds to any particular realization of the
randomized sequence and propose efficient algorithms to identify upper and lower bounds of the power. We then
obtain an “expected” power based on a first-order approximation to the variance formula, where the expectation is
taken with respect to all possible randomization sequences. Finally, we provide a variance formula for more general
settings where only the mean and coefficient of variation of cluster sizes, instead of exact cluster sizes, are known in
the design stage. We evaluate our methods through simulations and illustrate that the power of a SW-CRT decreases
as the variation in cluster sizes increases, and the impact is largest when the number of clusters is small.
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1. Introduction
Cluster Randomized Trials (CRTs) are studies in which clusters of individuals, rather than
individuals themselves, are randomized to intervention groups (Donner and Klar, 2000; Hayes
and Moulton, 2009). In a Stepped Wedge Cluster Randomized Trial (SW-CRT), clusters are
randomized to cross forward from control to intervention at certain time points commonly
termed as steps (Brown and Lilford, 2006; Hemming et al., 2015). The response is measured
between each step; either on the same individuals each time (cohort SW-CRT) or on different
individuals (cross-sectional SW-CRT). Table 1 provides a schematic for an example SW-
CRT. The popularity of SW-CRTs has increased in recent years and the design is often
implemented when a stepwise intervention initiation offers a practical solution.
The sample size required for a standard CRT is inflated compared with an individually
randomized trial because outcomes of participants from the same cluster are correlated.
A commonly-used inflation factor, also known as the design effect (DE), is [1 + (n − 1)ρ]
where n is the mean cluster size and ρ the intra-cluster correlation. Many articles (Kerry
and Bland, 2001; Manatunga et al., 2001; Hoover, 2002; Eldridge et al., 2006; van Breukelen
et al., 2007) have investigated the impact of cluster size variation on the power and sample
size of standard CRTs, and demonstrated that cluster size variation results in lower power.
A simple adjustment to the DE for standard CRTs (Eldridge et al., 2006) to account for
variability in cluster sizes is given by [1 + (n(1 + CV 2)− 1)ρ] where CV is the coefficient of
variation; the ratio of the standard deviation of cluster sizes to the mean cluster size. As an
example, a cluster size CV of 0.7 with a mean cluster size of n = 100 and an intra-cluster
correlation of ρ = 0.05, results in sample size increases of 41%.
A commonly-used approach to analyze data from a cross-sectional SW-CRT is based on a
linear mixed effects model (Hussey and Hughes, 2007). A DE based on such a model that
depends on equal cluster size (n), the intra-cluster correlation (ρ), the number of steps,
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and the number of time-points each cluster contributes n samples at baseline and between
each step has been proposed (Woertman et al., 2013). Although equal cluster sizes (n) are
desirable to achieve statistical efficiency, it may be infeasible logistically or non-optimal from
the sampling perspective. In some settings, the design may be to sample a fixed percentage
of the population, which naturally leads to unequal cluster sizes due to varying community
sizes and differential rate of participant refusal. A recent systematic review of 101 SW-CRTs
detected that 48% of studies included clusters that were known to vary in size (Kristunas
et al., 2017). Some cross-sectional SW-CRTs have clusters that are inherently variable in
size. For example, in a study of fall rates in hospital rehabilitation units (Poldervaart et al.,
2013, 2017), the number of patients enrolled per unit was limited by the number of beds
per ward, ranging from 14 to 90. Similarly, in the HEART impact trial (Hill et al., 2014,
2015) the goal was to recruit all eligible patients with chest pain, so the number recruited
per department varied with hospital size. While it may be possible to limit the recruitment
to the first M consenting participants from each site as in Bashour et al. (2013), this would
result in a prolonged recruitment period for those sites with a smaller candidate pool. It
would be useful to assess whether or not allowing cluster sizes to vary by recruiting more
participants in larger clusters would lead to a more feasible study design with similar power
even though the overall sample size required may be larger.
The impact of ignoring variation in cluster sizes on sample size calculation in SW-CRTs
is unclear. Through simulation studies, Kristunas et al. (2017) reported that a variation in
cluster size did not lead to notable loss of power in cross-sectional SW-CRTs with continuous
outcomes, but the authors noted they had only examined a small range of parameters. Martin
et al. (2018) calculated the power of a cross-sectional SW-CRT with unequal cluster sizes
by numerically inverting the precision matrix, and further noted that the power depended
on the order in which the variable size clusters were randomized to initiate the intervention.
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Martin et al. (2018) went on to utilize simulation methods with a gamma distribution for
cluster sizes to estimate the median and quartiles of the power across different randomization
sequences. Matthews (2016) targets the question of whether an optimal or near-optimal
ordering in which the variable size clusters initiate the intervention to achieve high power
can be determined without an exhaustive search across all possible randomization sequences.
He proposes a solution for the special cases where the intra-cluster correlation is extremely
large or small. Girling (2018) recently derived an analytical formula for the relative efficiency
(RE) of a SW-CRT with unequal compared to equal cluster sizes under a constrained
randomization setting. The derivation relies on several clusters being randomized at each
step, such that by stratifying the randomization procedure there is no inequality in the total
size of all the clusters randomized to initiate the intervention at each step. To the best of
our knowledge, analytical formulas for sample size and power estimation for cross-sectional
SW-CRTs in general settings with varying cluster sizes have not been derived.
Under a linear mixed effects model framework, in Section 2 we derive three analytical
formulas of variance estimates for power calculations that account for cluster size variation
in cross-sectional SW-CRTs. The first assumes cluster sizes and their order of randomization
are both known, and allows us to identify upper and lower bounds for the power of a SW-
CRT (Section 2.2 and 2.3). The second provides a closed form expression for the expected
variance before randomization when all cluster sizes are known (Section 2.4), and the third
approximates this value if only the mean and CV of cluster size can be estimated in the
planning stages of a SW-CRT (Section 2.5). In Section 2.6, we derive the DE for cross-
sectional SW-CRTs as compared to individually randomized trials accounting for varying
cluster sizes, a correction factor (CF) to correct sample size calculation and the expected
relative efficiency (RE) of a cross-sectional SW-CRT with unequal compared to equal cluster
sizes. Our simulation study and its results are described in Section 3, and illustrative
https://biostats.bepress.com/harvardbiostat/paper216
4 Biometrics, December 2018
examples on the impact of cluster size variation on the sample size and RE of a cross-
sectional SW-CRT are provided in Section 4. We end the paper with a Discussion (Section
5).
[Table 1 about here.]
2. Methods
2.1 Notation and Model
Henceforth, we consider a cross-sectional design with individuals k = 1, · · · , ni sampled from
cluster i = 1, · · · , I at every time-point j = 1, · · · , T . The landmark paper on SW-CRTs by
Hussey and Hughes (2007) proposes the following model for response variable Yijk:
Yijk = µ+ αi + βj +Xijθ + eijk, αi ∼ N(0, τ 2), eijk ∼ N(0, σ2e)
where αi is the random effect for cluster i, βj is a fixed effect corresponding to time j
(j = 1, ..., T − 1 with βT = 0 for identifiability), Xij is an indicator of treatment (1 =
intervention, 0 = control) in cluster i at time j, θ is the treatment effect, and eijk is the
subject-specific error independent of αi.
2.2 Treatment Effect Variance when Cluster Sizes and Order of Randomization Known
Under the linear mixed effects model, estimates for the fixed effects can be obtained us-
ing weighted least squares (WLS). Let Z be the IT × (T + 1) design matrix correspond-
ing to the parameter vector η = (µ, β1, β2, ..., βT−1, θ). Then, the WLS estimator is ηˆ =
(ZTV −1Z)−1(ZTV −1Y ) and the treatment effect denoted by θˆ is the (T + 1)th element of ηˆ.
The covariance matrix of ηˆ is (ZTV −1Z)−1, where V is a block diagonal matrix provided in
Web Appendix A.
To test the hypothesis H0 : θ = 0 versus θ = θA, we can use a Wald test based on
W = θˆ
/√
Var(θˆ) where θˆ is the estimated treatment effect from WLS. The approximate
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power for conducting a two-tailed test of size α is:
1− β ≈ Φ
 θA√
Var(θˆ)
− z1−α/2

where β is the probability of a type II error, 1−β is the statistical power, Φ is the cumulative
standard normal distribution function, z1−α/2 is the (1 − α/2)th quantile of the standard
normal distribution function, and Var(θˆ) is the (T + 1), (T + 1) element of the covariance
matrix (ZTV −1Z)−1
A closed form expression for the treatment effect variance given one particular realization
of the randomization sequence can be derived (See Web Appendix A for details):
Var(θˆ|P = p) = fT (f + gT )
fT (f + gT )(`− z)− (f + gT )y2 − f(Tw − `2) (1)
where
f =
I∑
i=1
1
σ2i + Tτ
2
, g =
I∑
i=1
τ 2
σ2i (σ
2
i + Tτ
2)
, ` =
I∑
i=1
T∑
j=1
Xij
σ2i
,
z =
I∑
i=1
τ 2
σ2i (σ
2
i + Tτ
2)
(
T∑
j=1
Xij
)2
, y =
I∑
i=1
T∑
j=1
Xij
σ2i + Tτ
2
, w =
T∑
j=1
(
I∑
i=1
Xij
σ2i
)2
and σ2i = σ
2
e/ni. When the sample size is the same for all clusters this variance simplifies to
the variance provided in equation 8 of Hussey and Hughes (2007) (See Web Appendix B).
Inspection of the terms in the variance formula given in equation 1 reveals that components
of the denominator (`, z, y2, Tw − `2) depend upon the order in which the clusters are
randomized to intervention; P = p in equation 1 denotes a particular realization of the
randomization sequence. For example, ` =
I∑
i=1
T∑
j=1
Xij
σ2i
= 1
σ2e
(n1(X11+ ...+X1T )+ ...+nI(XI1+
...+XIT )) will be larger if a large cluster is randomized to intervention first, i.e. if n1 is large.
This is because in SW-CRTs the first cluster randomized receives treatment for the most time
periods, so as Xij is the indicator of treatment status, X11 + ...+X1T will be greater than or
equal to the other summations. If randomization of all clusters in a SW-CRT has taken place,
this variance formula could be utilized to check the power after randomization. If the power
is too low, the formula could be used to determine the number of additional measurements
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needed to increase the power. As it is customary to calculate the power in planning stages of
a trial before randomization, in Section 2.3 and 2.4 we provide a method to find the upper
and lower bound of the treatment effect variance across all possible randomizations, as well
as a closed form expression for the expected value of the variance to obtain the study power
in an average sense.
2.3 Method to Find Upper and Lower Bounds for the Treatment Effect Variance
To find the upper and lower bounds for the power across all possible randomizations, the
maximum and minimum of the denominator D(v1, · · · , vI) of the variance of the treatment
effect estimator in equation 1 was sought. This requires optimizing D(v1, · · · , vI) over the
order of varying cluster sizes; that is,
minimize/maximize: D(v1, · · · , vI)
subject to: (v1, · · · , vI) is a permutation of (n1, · · · , nI)
The above optimization problem is classified as an assignment problem with a quadratic
objective, since D(v1, · · · , vI) is quadratic in v1, · · · , vI . In general, an assignment problem
with a non-linear objective is not only NP-hard (i.e. cannot be solved in polynomial time),
but also does not have a “good” algorithm to solve it other than cycling through all I!
permutations. Fortunately, a reparametrization involving permutation matrices reformulates
the problem into a mixed-integer quadratic programming (MIQP) problem, which, while still
NP-hard, has excellent algorithms to solve it. Specifically, the reparametrization (see Web
Appendix C) takes the form
minimize/maximize: RTMR +DTR
subject to:
I∑
i=1
R(s−1)I+i = 1 ∀s = 1, · · · , I
I∑
s=1
R(s−1)I+i = 1 ∀i = 1, · · · , I
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R(s−1)I+i ∈ {0, 1}
where
• R is a vector of length I2 decision variables
• M is an I2 × I2 matrix with elements
M(s−1)I+i,(t−1)I+j = −(f + gT )
(
I∑
k=1
Xsk
)(
I∑
k=1
Xtk
)
1
(σ2i + τ
2T )(σ2j + τ
2T )
− f
[
T
I∑
k=1
XskXtk −
(
I∑
k=1
Xsk
)(
I∑
k=1
Xtk
)]
1
σ2i σ
2
j
for s, t, i, j = 1, · · · , I
• D is a vector of length I2 with elements
D(t−1)I+j = fT (f + gT )
( I∑
k=1
Xtk
)
1
σ2j
−
(
I∑
k=1
Xtk
)2
τ 2
σ2j (σ
2
j + τ
2T )

for t, j = 1, · · · I
The above form can now be solved by algorithms implemented by solvers such as Gurobi
(2018). The decision variable vector R is a vectorization of the permutation matrix which
encodes the order clusters should be placed in the randomization sequence to obtain highest
or lowest possible power. For example, suppose there are four clusters of size 10, 15, 45 and
50. An optimal solution R = (0, 0, 1, 0, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 1) is a vectorization of the
matrix 
0 0 1 0
0 1 0 0
1 0 0 0
0 0 0 1

with optimal order

0 0 1 0
0 1 0 0
1 0 0 0
0 0 0 1


10
15
45
50

=

45
15
10
50

We require the vectorized form R in order to feed the decision variables into a solver. One
sequence that optimizes the objective function will be found using this method and the
maximum/minimum power of the SW-CRT design can be obtained by using this optimal
sequence to first calculate the treatment effect variance using equation 1 and then to estimate
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the power of the Wald test using this variance. We note that the randomization sequence
achieving highest or lowest power can be non-unique. In the example, a sequence of 50, 10,
15 and 45 would also attain the same maximum power. An exhaustive search over all the
possible randomizations could be conducted to identify all sequences of the cluster sizes that
have higher power. However, for design purposes, we are most interested in the best and
worst case scenarios for the power, identifying all sequences that are associated with each
extreme case is not necessary.
2.4 Expected Treatment Effect Variance when Cluster Sizes Known
When all the cluster sizes are known prior to randomization, we derive a closed form expres-
sion for first order approximation of the expected value of Var(θˆ|P ), where the expectation
is taken across all possible randomization realizations.
To proceed, we consider the settings described in Woertman et al. (2013) where q clusters
are randomized at each step, where q is any divisor of the total number of clusters I, where
each cluster contributes samples at b baseline time-points before any cluster begins the
intervention and at t time-points after each step. Hence, cross-sectional samples from the
clusters will be taken at T = (I/q)t + b time-points. Such balanced designs are commonly-
used in practice. If K = I/q represents the number of steps, then T the total time-points
can also be written Kt + b. An an example, a design corresponding to b = 1, t = 2, q = 2
results in the following treatment status matrix, where Xij is the indicator of treatment
Hosted by The Berkeley Electronic Press
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(1=intervention, 0=control) in cluster i at time j:
X11 X12 X13 X14 X15 X16 · · · X1(T−1) X1T
X21 X22 X23 X24 X25 X26 · · · X2(T−1) X2T
X31 X22 X33 X34 X35 X36 · · · X3(T−1) X3T
X41 X22 X43 X44 X45 X46 · · · X4(T−1) X4T
X51 X22 X53 X54 X55 X56 · · · X5(T−1) X5T
...
...
...
...
...
...
. . .
...
...
XI1 XI2 XI3 XI4 XI5 XI6 · · · XI(T−1) XIT

=

0 1 1 1 1 1 · · · 1 1
0 1 1 1 1 1 · · · 1 1
0 0 0 1 1 1 · · · 1 1
0 0 0 1 1 1 · · · 1 1
0 0 0 0 0 1 · · · 1 1
...
...
...
...
...
...
. . .
...
...
0 0 0 0 0 0 · · · 1 1

In the variance formula given in equation 1, three terms in the denominator, (`− z), (y2)
and (Tw−`2) depend on the order clusters are randomly assigned to initiate the intervention.
To calculate the three expectations, E(`− z), E(y2) and E(Tw− `2), we derived P(Xik = 1),
the probability cluster i is treated at time-point k, and P(Xik = 1, Xjl = 1), the probability
cluster i is treated at time-point k and cluster j is treated at time-point l, as follows (Web
Appendix D):
P(Xik = 1) =
dk−b
t
eq
I
P(Xik = 1, Xjl = 1) =
(dk−b
t
e ∧ d l−b
t
e)q
I
(dk−b
t
e ∨ d l−b
t
e)q − 1
I − 1
where d·e is the ceiling function, a ∧ b = min(a, b) and a ∨ b = max(a, b)
Based on these results and a first-order approximation E(A/B) ≈ E(A)/E(B), we obtained
the following formula to approximate the expected value of Var(θˆ|P ):
EP (Var(θˆ|P )) ≈ fT (f + gT )
fT (f + gT )E(`− z)− (f + gT )E(y2)− fE(Tw − `2) (2)
where
E(`− z) = T − b+ t
2
(
NSW
σ2e
− 1
3T
(
NSW
σ2e
− f
)
(2T − 2b+ t)
)
,
NSW =
I∑
i=1
ni,
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E(y2) =
T − b+ t
12(I − 1)(s1I(T − b− t) + f
2(3I(T − b+ t)− 2(2T − 2b+ t)),
s1 =
I∑
i=1
1
(σ2i + Tτ
2)2
,
E(Tw − `2) = (T − b+ t)N
2
SW
12(T − b)σ4e
(
(T + b)(T − b− t)
I
κ2 + T 2 + 2bT − tT − 3b2 + 3bt
)
,
κ2 =
I2
N2SW (I − 1)
I∑
i=1
(
ni − NSW
I
)2
and here we use κ to denote the sample coefficient of variation (CV) of cluster sizes.
2.5 Approximate Expected Treatment Effect Variance with Mean and Coefficient of
Variation (CV) of Cluster Sizes
In the design stage of a SW-CRT, each cluster size may not be known, instead, the in-
vestigators may have information on the average and CV of the cluster sizes. We derived
the following variance formula to approximate the variance formula provided in equation 8
of Hussey and Hughes (2007) for the same type of design described in Section 2.4 where
information on actual cluster sizes ni is replaced by their mean and CV:
EP (Var(θˆ|P )) ≈ ITσ
2(σ2 + Tτ 2)
σ2(ITU − U2 − I2C) + Tτ 2(ITU − IV − I2C) (3)
where
C =
(T − b+ t)
12(T − b)
(
(T + b)(T − b− t)
I
κ2 + T 2 + 2bT − tT − 3b2 + 3bt
)
U =
I(T − b+ t)
2
, V =
I(T − b+ t)(2T − 2b+ t)
6
, σ2 =
Iσ2e
NSW
The derivation used the first order Taylor approximation of the terms f and s1 about the
mean cluster size (See Web Appendix E for details).
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2.6 Design Effect (DE), Correction Factor (CF) and Relative Efficiency (RE) for Designs
with Unequal Cluster Sizes
From the approximation of the treatment effect variance in Section 2.5, we derived a DE for
a SW-CRT with unequal cluster sizes relative to an individually randomized trial of total
size NSW = nI, the number of participants sampled at each time-point of a cross-sectional
SW-CRT (See Web Appendix F):
DEw,κ =
3(T − b)T (1− ρ)(1− ρ+ Tρn)
(T − b+ t)(T − b− t)(T (2(1− ρ) + (T + b)nρ)− T+b
I
κ2(1− ρ+ Tnρ)) (4)
where ρ = τ 2/(σ2e + τ
2) is the intra-cluster correlation and n = NSW/I is the mean cluster
size. When the CV denoted by κ in equation 4 is zero, DEw,κ reduces to DEw a design effect
derived in Woertman et al. (2013) for a cross-sectional SW-CRT with equal cluster sizes
compared to an individually randomized trial of size NSW (See Web Appendix G). DEw,κ
summarizes the inflation required for a SW-CRT with unequal cluster sizes compared to an
individually randomized trial of total size NSW . To compare to an individually randomized
trial of total size TNSW , the overall number of participants sampled in a cross-sectional
SW-CRT, the design effect would be T DEw,κ.
In addition, we derive a correction factor (CF) in total sample size at each time-point
accounting for varying cluster sizes (See Web Appendix H):
NSW ≈ DEwNind + CF (5)
where
• Nind = 4(σ2e + τ 2)(z1−β + z1−α/2)2/θ2A is the total sample size required for an individually
randomized trial with an anticipated treatment effect of θA
• DEw = [3(T − b)(1− ρ)(1− ρ+ Tρn)]/[(T − b+ t)(T − b− t)(2(1− ρ) + (T + b)nρ)] is the
Woertman et al. (2013) design effect
• CF = nκ2(1 − AT) is the correction factor for cluster size variation with an attenuation
term (AT ) defined as AT = (T − b)(1− ρ)/[T (2(1− ρ) + (T + b)nρ)]
https://biostats.bepress.com/harvardbiostat/paper216
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The required sample size at each time-point for a SW-CRT can be calculated by multiplying
the unadjusted sample size in an individually randomized trial by the Woertman et al. (2013)
DEw, and then adding our CF. Before applying the sample size formula knowledge of the
following is required: the mean cluster size (n), the cluster size CV (κ), the number of
baseline time-points (b), the number of time-points between each step (t), and the total
number of time-points equal to the number of steps (K) multiplied by the number of time-
points between each step (t) plus the baseline time-points (b), i.e. T = Kt+ b. The formulas
for individually randomized trials usually result in the number of participants per treatment
arm, but the total number of participants is needed here. After utilizing the formula, the
required number of clusters I is dNSW/ne and the number of clusters switching treatment
at each step is dI/Ke, where d·e is the ceiling function. Woertman et al. (2013) suggest
distributing the clusters as evenly as possible over the steps. As noted in Baio et al. (2015),
the overall sample size in terms of participants each contributing one measurement in a cross-
sectional design is actually TNSW = T DEw Nind if the cluster size is considered fixed and
TNSW = T (DEw Nind + CF ) using our formulation that accounts for cluster size variation.
The correction factor CF slightly underestimates nκ2 and often times can simply be
approximated by nκ2, since the attenuation term AT is typically negligible. When n is
large (e.g. 5,000), there is a high intra-cluster correlation (e.g. ρ = 0.4), there are a few
baseline time-points (e.g. b = 2), and a small number of total time-points (e.g. T = 4), we
can calculate AT = 6.25× 10−6. In a more extreme small-sample scenario, when n is small
(e.g. 5), intra-cluster correlation is low (e.g. ρ = 0.01), there is one baseline time-point (e.g.
b = 1), and the total time-points is large (e.g. T = 25), we can calculate AT = 0.29.
In many cases, the CF corresponds to including κ2 additional clusters to account for
cluster size variation. The calculation requires the total number of time-points (T ) to remain
constant, and hence the number of steps (K) to remain the same. Therefore, it would only
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be directly applicable if κ2 is divisible by the number of steps (K) in the proposed design.
For example, with a CV of approximately 1.4 (κ ≈ 1.4) and a design with two steps (K = 2),
you would include two additional clusters, one per step, in the design to account for cluster
size variation.
The approximate expected Relative Efficiency (RE) of a design with unequal cluster sizes
compared to equal can be derived (See Web Appendix I) by the ratio of the DEw derived
by Woertman et al. (2013) to our DEw,κ in equation 4:
RE ≈ DEw
DEw,κ
= 1− κ
2
I
(
1− AT
)
(6)
As noted above, the attenuation term AT is positive and typically small, so the efficiency
loss by having unequal cluster sizes can be approximated as 1− κ2/I in most cases.
3. Simulation Study
3.1 Simulation Study Design
In our proposed method, cluster i has size ni, which is fixed for all sampling time-points
T . At each of the T time-points a total of NSW participants contribute data from the I
clusters. For each simulation scenario, the total number of participants contributing data
(NSW ) at each time-point was kept fixed and so was the number of participants contributing
data from each cluster, i.e. ni for i = 1, ..., I. The number of participants contributing data
from each cluster (ni for i = 1, ..., I) was determined by the following procedure. Firstly,
the total number of participants contributing data at each time-point (NSW ) was randomly
split into two groups, with one group containing on average 50%, 60%, 70%, 80% or 90% of
the participants, then either: 1. within each group, participants were randomly assigned to
one of I/2 clusters with equal chance, 2. all the participants from the smaller group were
assigned to one cluster, and participants in the larger group were randomly assigned to the
remaining I − 1 clusters with equal chance, or 3. all the participants from the larger group
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were assigned to one cluster, and participants in the smaller group were randomly assigned to
the remaining I−1 clusters with equal chance. This procedure created cluster size imbalance
so that the CV of cluster size variation (κ) ranged from 0 to a maximum of 3.5.
For each chosen NSW and study design, the effect size (θA) was set so that the power
calculated based on a fixed cluster size using the variance in equation 8 of Hussey and
Hughes (2007) would be 80%. Then the estimated power accounting for cluster size variation
when all cluster sizes are known was calculated using the variance formula in equation 2.
Additionally, the approximate power when only a cluster size mean (n) and CV (κ) is known
prior to randomization using equation 3 was calculated. To estimate the empirical power,
for each SW-CRT the variable size clusters were placed in a random order and data were
simulated using the model given in Section 2.1 (Hussey and Hughes, 2007). For convenience,
both µ and βj for j = 1, .., T − 1 were set at zero. For continuous outcomes, without loss of
generality, the total variance σ2t = σ
2
e + τ
2 was fixed at 1, so that the between-cluster and
within-cluster variances could then be written as τ 2 = ρ and σ2e = 1− ρ, respectively, where
ρ is the intra-cluster correlation. Data were analyzed by the same linear mixed effect model
using the “lmer” function from the “lme4” package in R statistical software. For simulations
involving count outcomes, σ2 = (1 + eθA)
/
2 and τ 2 = (ρσ2)
/
(1 − ρ). αi were drawn from
independent N(0, τ 2) and exp(αi + XijθA) calculated. Count data were then derived from
a Poisson distribution with rate exp(αi +XijθA). Data were analyzed using the generalized
linear mixed effects model with log link, implemented in the R function “glmer”. For all
simulations, a two-tailed Wald test for the treatment effect was generated, and the empirical
power calculated by the proportion of simulated results with p-values that were < 0.05.
In the simulations presented, the intra-cluster correlation ρ was set at 0.05 and the mean
cluster size n at 30. For continuous outcomes, we simulated the cases where there were 4 or
6 clusters (I = 4 or 6), q = 1 cluster randomized at each step, b = 1 baseline time-point and
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t = 1 time-point between each step. Additionally, we simulated the case involving 12 clusters
(I = 12) where q = 3 were randomized at each step, there were b = 2 baseline time-points
and t = 3 time-points between each step. For count data we used the case with I = 6,
q = 1, b = 1 and t = 1. A Monte Carlo estimate of the error around the empirical power was
computed for two cases (first: I=4, q=1, t=1, b=1, n=30, CV=0.73; second: I=12, q=3, t=3,
b=2, n=30, CV=0.69) for continuous outcomes and used to guide the choice of the number
of simulations. Using 3,500 simulations resulted in a Monte Carlo error of 6 0.75%, so we
would expect most empirical power estimates to be within 1.5% of the true power. In the
case with I = 4, q = 1, b = 1 and t = 1, there would be a total of 120 participants measured
at each cross-sectional time-point (NSW = 120) and 600 participants contributing data over
the course of SW-CRT (TNSW = 600).
To evaluate the impact of the order of randomization for particular known cluster sizes for a
design with 6 clusters (I = 6) and a continuous outcome, the power was calculated for each of
the 6! = 720 randomization sequences using equation 1. We then used the method described
in Section 2.3 to create upper and lower bounds for the power across all randomization
sequences, and additionally simulated the empirical power for each randomization sequence
to observe how close the estimated power using equation 1 was to the truth.
3.2 Simulation Study Results
Figure 1 displays the power as the cluster size varies. For the four simulation scenarios one
can observe that as the cluster size CV (κ) increases the power decreases. The expected power
when all the clusters sizes are known calculated using the variance formula in equation 2,
displayed by the dotted light blue line, is very similar to the approximation using the cluster
size mean and CV by equation 3 denoted by the solid pink line. This figure appears in color
in the electronic version of this article, and color refers to that version. By comparing the
orange squares showing the empirical power, we can see the expected power is well estimated.
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Most of the deviation of the orange squares from the dotted light blue and solid pink lines
is due to the particular order clusters received intervention in that simulation as we know
the Monte Carlo error is generally 6 0.75%. The impact of the randomization sequence is
explored in more detail in the next paragraph.
[Figure 1 about here.]
Figure 2 displays the power for each possible randomization sequence of 6 clusters where
the cluster sizes are 4, 11, 18, 21, 22 and 104, resulting in an average cluster size of 30. If
all clusters had equal sample size of 30, the study would have achieved 80% power. Using
equation 2 where all clusters sizes are known prior to randomization or equation 3 when only
the cluster size mean and CV of κ = 1.23 is known in the design stage, the study would have
an average power of just under 70%. Power estimates for each randomization sequence using
equation 1 are displayed by the green dots in Figure 2A. This figure appears in color in the
electronic version of this article, and color refers to that version. The green dots are almost
entirely covered by the orange squares displaying the empirically simulated power in Figure
2B. An upper and lower bound for the power was obtained using the method described in
Section 2.3 and is displayed in Figure 2 by dashed dark blue lines. This correctly finds the
maximum and minimum power for estimates derived using equation 1 for the treatment
effect variance displayed by green dots. For the empirically simulated power, the lower and
upper bounds are very close to the lowest and highest simulated powers.
[Figure 2 about here.]
4. Illustrative Examples
4.1 Design of a Cross-sectional SW-CRT with Unequal Cluster Sizes
Suppose we are interested in designing a cross-sectional SW-CRT with two steps (K = 2),
one baseline time-point (b = 1) and one time-point between each step (t = 1) to detect
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a treatment effect (θA) of 0.27 with a mean cluster size (n) of 100. Assuming no cluster
size variation, the study would need 6 clusters (I = 6) with 3 randomized at each step
(q = 3). Based on equation 5, under cluster size variation, the overall sample size (TNSW )
and number of clusters (I) required to achieve 80% power is plotted as a function of CV
(κ) and is shown in Figure 3. If the cluster size CV was κ = 1.4, the SW-CRT design with
two steps would instead require a total of 8 clusters (I = 8) with 4 randomized at each step
(q = 4) (Figure 3B). This represents an inflation of overall sample size (TNSW ) from 1800
to 2400, which is 33% (Figure 3A). In this example with only two steps and CV of κ = 1.4
requiring two additional clusters is easy to implement into the original design, however in
many cases this will not be the case. If the CV was 1, only one additional cluster would be
required. It is unknown if this cluster should be randomized to intervention at the first or
second step. Therefore, the design may have to be changed to have a different number of
steps or larger mean cluster size, and finding a design that is practical with adequate power
may be an iterative process.
[Figure 3 about here.]
4.2 Relative Efficiency (RE) Comparing Unequal to Equal Cluster Sizes
We take as the first example a case where there are a small number of clusters (I = 4), so
that the RE of the SW-CRT design is notably reduced by cluster size variation. Suppose
that one cluster is randomized at each step (q = 1), there is one baseline time-point (b = 1),
one time-point between each step (t = 1), the mean cluster size (n) is either 30 or 100, the
intra-cluster correlation (ρ) is 0.01, 0.05 or 0.25, and the CV (κ) of cluster size ranges from
zero to 1.5. Then the RE for the SW-CRT with unequal cluster sizes to equal is displayed in
Figure 4A. With a CV of κ = 0.5, there is roughly 5% efficiency loss and for a CV of κ = 0.75
there is greater than 10% efficiency loss in all cases. The efficiency loss is similar for a mean
cluster size (n) of 30 or 100 when the intra-cluster correlation is above 0.01 (ρ > 0.01).
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For the second example, we illustrate that how you divide the clusters over steps does
not have much impact on the RE for unequal compared to equal cluster sizes. We take the
number of clusters (I) to be 12, the mean cluster size (n) to be either 30 or 100, the intra-
cluster correlation (ρ) to be 0.05, the number of clusters randomized at each step (q) to be
1, 2, 3 or 4, and CV (κ) to range from zero to 1.5. On Figure 4B, note that because there
are more clusters than in the first example, the impact of cluster size variation overall is less.
However, when the CV (κ) is greater than around 1.1 there is more than 10% efficiency loss.
The efficiency loss is almost identical whether the average cluster size is 30 or 100, or if a
different number of clusters are randomized at each step.
[Figure 4 about here.]
5. Discussion
When designing a cross-sectional SW-CRT with varying cluster sizes, this variation needs
to be taken into consideration to ensure the study is adequately powered. While the effect
of unequal cluster sizes on study power appears to be smaller than for standard CRTs; the
reduction in power is not negligible particularly when the number of clusters is small or the
cluster size CV is greater than one.
We derived analytical formulas for calculating the power of a cross-sectional SW-CRT
accounting for cluster size variation. In the presence of unequal cluster sizes, the power of a
SW-CRT depends on the order of randomization. The variance formula derived in equation
1 is associated with a particular realization of the randomization. Based on this, we have
devised computationally efficient algorithms to identify the upper and lower bounds for power
without having to resort to an exhaustive search.
Under settings where an equal number of clusters are randomized to treatment initiation
at each step, we provide formulas to estimate the average power loss using either the actual
Hosted by The Berkeley Electronic Press
Power Calculation for Cross-Sectional Stepped Wedge Cluster Randomized Trials with Variable Cluster Sizes 19
cluster sizes or the projected average and CV of the cluster sizes and note that the power
loss can be substantial. If the number of clusters are sufficiently large so that several clusters
are randomized to treatment initiation and there is no substantial inequality in the total
size of all clusters randomized to treatment initiation at each step, the power loss will be
alleviated (Girling, 2018). However, in settings where total numbers of clusters are not large,
this would not be feasible. Indeed, SW-CRTs are particularly suited for the situation where
the number of clusters is small.
The linear mixed effects model used in this paper, based on work by Hussey and Hughes
(2007), assumes random cluster effects, fixed time effects, no cluster by time interaction and
no treatment by time interaction. In theory, the model for cross-sectional SW-CRT designs
could be adapted to incorporate more flexible modeling assumptions, and a variance derived
in a similar fashion by the WLS approach to estimate the power. Alternatively, for more
complicated analyses, a simulation approach similar to that proposed by Baio et al. (2015)
may be employed.
Further work is necessary for cohort SW-CRTs. Hooper et al. (2016) proposed DEs for
cohort designs with equal cluster sizes. Utilizing the DE for cross-sectional design for a cohort
study will often result in an underpowered study as the autocorrelation between time-points
is not taken into account. As the average RE of a cross-sectional SW-CRT with unequal
compared to equal cluster sizes does depend on the intra-cluster correlation (ρ) we expect
in a cohort design the autocorrelation between time-points to play a role in determining the
RE of unequal compared to equal cluster sizes for a cohort SW-CRT. However, the efficiency
loss for a cross-sectional SW-CRT was largely driven by the number of clusters and cluster
size CV. This may also be the case for cohort designs, and further exploration is needed.
The formulas for variance and DE in this paper are derived under a linear model and
therefore are particularly suited to a continuous or count outcome. For a SW-CRT with a
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binary outcome, Zhou et al. (2018) pointed out that the power formulas derived under a
linear model can be liberal in some settings and conservative under others, and proposed a
method for power calculation based on a likelihood approach. Li et al. (2018) proposed a
method to determine sample size for binary outcomes within the framework of generalized
estimating equations. Both methods assume equal cluster sizes. In future work we aspire
to investigate power and sample size formulas for binary outcomes accounting for unequal
cluster sizes.
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C) 12 Clusters, q=3, b=2, t=3; continuous D) 6 Clusters, q=1, b=1, t=1; count
A) 4 Clusters, q=1, b=1, t=1; continuous B) 6 Clusters, q=1, b=1, t=1; continuous
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Figure 1. Estimated Power as the Cluster Size Coefficient of Variation (κ) Increases for
Four Simulation Scenarios. q is the number of clusters randomized at each step, b is the
number of time-points each cluster contributes samples at baseline, t is the number of time-
points each cluster contributes samples between each step. i) fixed cluster size: uses the
variance formula in equation 8 of Hussey and Hughes (2007), ii) cluster sizes known: uses
the variance formula in equation 2, iii) cluster size CV: uses the variance formula in equation
3, iv) empirical: the empirically simulated power from 3,500 simulations. This figure appears
in color in the electronic version of this article.
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iii) cluster size CV
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Figure 2. Power for All Possible Randomizations with Upper and Lower Bound Indicated
for a SW-CRT with 6 Clusters of Mean Size (n) 30 and CV (κ) of 1.23. i) fixed cluster size:
uses the variance formula in equation 8 of Hussey and Hughes (2007), ii) cluster sizes known:
uses the variance formula in equation 2, iii) cluster size CV: uses the variance formula in
equation 3, iv) randomization order: uses the variance formula in equation 1, v) bounds:
uses the method described in Section 2.3, vi) empirical: the empirically simulated power
from 3,500 simulations. This figure appears in color in the electronic version of this article.
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Figure 3. A) Overall Sample Size (TNSW ), B) Number of Clusters (I) Required to Achieve
80% Power for a SW-CRT with Two Steps. i) fixed cluster size: estimates the sample size
using DEw (Woertman et al., 2013), ii) cluster size CV: estimates the sample size using
equation 5. This figure appears in color in the electronic version of this article.
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A) 4 Clusters B) 12 Clusters
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Figure 4. Relative Efficiency (RE) for A) Four Clusters with q=1 Randomized at Each
Step (T=5), B) Twelve Clusters with q=1-4 Randomized at Each Step (T=4, 5, 7, 13). n is
the mean cluster size and ρ the intra-cluster correlation. This figure appears in color in the
electronic version of this article.
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Table 1
Schematic of a Stepped Wedge Cluster Randomized Trial (SW-CRT) with one baseline time-point (b = 1), two
clusters randomized to initiate the intervention at each step (q = 2), two time-points between each step (t = 2) and
four steps (K = 4). 0 represents control and 1 intervention.
Time
1 2 3 4 5 6 7 8 9
C
lu
st
er
1 0 1 1 1 1 1 1 1 1
2 0 1 1 1 1 1 1 1 1
3 0 0 0 1 1 1 1 1 1
4 0 0 0 1 1 1 1 1 1
5 0 0 0 0 0 1 1 1 1
6 0 0 0 0 0 1 1 1 1
7 0 0 0 0 0 0 0 1 1
8 0 0 0 0 0 0 0 1 1
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Web Appendix A
Let ni denote the size of each cluster i = 1, · · · , I at every time-point j = 1, · · · , T . Let σ2i = σ2e/ni. The design
matrix Z ∈ RIT×(T+1) takes the form
Z =

Z1
...
ZI
 , where Zi =
1T IT−1
0ᵀT−1
Xi

where 1T and 0T are vectors of 1’s and 0’s of length T , respectively, IT is the T × T identity matrix, and Xi =
(Xi1, · · · , XiT )ᵀ denotes the treatment status of cluster i at each time j, j = 1, ..., T . The inverse of the variance
matrix of the outcome vector (Yijk), k = 1, ..., ni, V ∈ RIT×IT is block-diagonal, V = diag(V1, · · · , VI), with each
block
Vi = σ
2
i IT + τ
21T1
ᵀ
T
Therefore, block-matrix multiplication produces
ZᵀV −1Z =
I∑
i=1
Zᵀi V
−1
i Zi
By Woodbury’s formula,
V −1i =
1
σ2i (σ
2
i + Tτ
2)
[(σ2i + Tτ
2)IT − τ21T1ᵀT ]
And so
Zᵀi V
−1
i Zi =
1
σ2i (σ
2
i + Tτ
2)
[(σ2i + Tτ
2)Zᵀi Zi − τ2(Zᵀi 1)(1ᵀZi)]
=
1
σ2i (σ
2
i + Tτ
2)
(σ2i + Tτ2)

T 1ᵀT−1 1
ᵀ
TXi
1T−1 IT−1 Xi,−T
1ᵀTXi X
ᵀ
i,−T X
ᵀ
iXi
− τ2

T 2 T1ᵀT−1 T1
ᵀ
TXi
T1T−1 1T−11
ᵀ
T−1 (1
ᵀ
TXi)1T−1
T1ᵀTXi (1
ᵀ
TXi)1
ᵀ
T−1 X
ᵀ
i 1T1
ᵀ
TXi


=
1
σ2i (σ
2
i + Tτ
2)

Tσ2i σ
2
i 1
ᵀ
T−1 σ
2
i 1
ᵀ
TXi
σ2i 1T−1 (σ
2
i + Tτ
2)IT−1 − τ21T−11ᵀT−1 (σ2i + Tτ2)Xi,−T − τ2(1ᵀTXi)1T−1
σ2i 1
ᵀ
TXi (σ
2
i + Tτ
2)Xᵀi,−T − τ2(1ᵀTXi)1ᵀT−1 (σ2i + Tτ2)XᵀiXi − τ2Xᵀi 1T1ᵀTXi

and so
ZᵀV −1Z =

Tf f1ᵀT−1 y
f1T−1 (f + gT )IT−1 − g1T−11ᵀT−1
∑I
i=1
Xi,−T
σ2i
− τ2h1T−1
y
∑I
i=1
X
ᵀ
i,−T
σ2i
− τ2h1ᵀT−1 `− z

where
f =
I∑
i=1
1
σ2i + Tτ
2
, g =
I∑
i=1
τ2
σ2i (σ
2
i + Tτ
2)
, ` =
I∑
i=1
T∑
j=1
Xij
σ2i
,
z =
I∑
i=1
τ2
σ2i (σ
2
i + Tτ
2)
(
T∑
j=1
Xij
)2
, y =
I∑
i=1
T∑
j=1
Xij
σ2i + Tτ
2
, h =
I∑
i=1
T∑
j=1
Xij
σ2i (σ
2
i + Tτ
2)
Note the identities
f + gT =
I∑
i=1
1
σ2i
, ` = y + Tτ2h
which we shall freely use in the rest of the proof.
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3The variance of the treatment effect, Var(θˆ), is the (T + 1), (T + 1) component of (ZᵀV −1Z)−1. Let
A11 =
 Tf f1ᵀT−1
f1T−1 (f + gT )IT−1 − g1T−11ᵀT−1

A21 = A
ᵀ
12 =
[
y
∑I
i=1
X
ᵀ
i,−T
σ2i
− τ2h1ᵀT−1
]
A22 = `− z
Then,
[(ZᵀV −1Z)−1](T+1),(T+1) = (A22 −A21A−111 A12)−1
The first task is to compute the components of A−111 , which can be computed through block-matrix inversion as
[A−111 ]11 =
(
(Tf)− f1ᵀT−1[(f + gT )IT−1 − g1T−11ᵀT−1]−1f1T−1
)−1
=
(
(Tf)− f1ᵀT−1
(f + g)IT−1 + g1T−11
ᵀ
T−1
(f + g)(f + gT )
f1T−1
)−1
=
(
(Tf)− f
2(f + g)(T − 1) + f2g(T − 1)2
(f + g)(f + gT )
)−1
=
f + g
f(f + gT )
[A−111 ]21 = [A
−1
11 ]
ᵀ
12 = −
(
(f + g)IT−1 + g1T−11
ᵀ
T−1
(f + g)(f + gT )
)
(f1T−1)
(
f + g
f(f + gT )
)
= − 1T−1
f + gT
[A−111 ]22 =
(
(f + g)IT−1 + g1T−11
ᵀ
T−1
(f + g)(f + gT )
)
+
1T−1
f + gT
(f1ᵀT−1)
(
(f + g)IT−1 + g1T−11
ᵀ
T−1
(f + g)(f + gT )
)
=
1
f + gT
(IT−1 + 1T−11
ᵀ
T−1)
And so
A21A
−1
11 A12 =
[
y
∑I
i=1
X
ᵀ
i,−T
σ2i
− τ2h1ᵀT−1
]
1
f + gT
 f+gf −1ᵀT−1
−1ᵀT−1 IT−1 + 1T−11ᵀT−1

 y∑I
i=1
Xi,−T
σ2i
− τ2h1T−1

=
1
f + gT
(
f + g
f
y2 − 2yη + ζ
)
where
η
def
= 1ᵀT−1
(
I∑
i=1
Xi,−T
σ2i
− τ2h1T−1
)
=
I∑
i=1
T−1∑
j=1
Xij
σ2i
−
I∑
i=1
T∑
j=1
τ2(T − 1)Xij
σ2i (σ
2
i + Tτ
2)
= y + τ2h−
I∑
i=1
XiT
σ2i
and
ζ
def
=
(
I∑
i=1
Xᵀi,−T
σ2i
− τ2h1ᵀT−1
)
(IT−1 + 1T−11
ᵀ
T−1)
(
I∑
i=1
Xi,−T
σ2i
− τ2h1T−1
)
=
(
I∑
i=1
Xᵀi,−T
σ2i
− `− y
T
1ᵀT−1
)
(IT−1 + 1T−11
ᵀ
T−1)
(
I∑
i=1
Xi,−T
σ2i
− `− y
T
1T−1
)
=
(
I∑
i=1
Xᵀi,−T
σ2i
− `
T
1ᵀT−1
)
(IT−1 + 1T−11
ᵀ
T−1)
(
I∑
i=1
Xi,−T
σ2i
− `
T
1T−1
)
+ 2
y
T
1ᵀT−1(IT−1 + 1T−11
ᵀ
T−1)
(
I∑
i=1
Xi,−T
σ2i
− `
T
1T−1
)
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+
y
T
1ᵀT−1(IT−1 + 1T−11
ᵀ
T−1)
y
T
1T−1
=
[
w − `
2
T
]
+ 2y
(
y
T
+ τ2h−
I∑
i=1
XiT
σ2i
)
+
y2
T
(T − 1)
where
w =
T∑
j=1
(
I∑
i=1
Xij
σ2i
)2
and so
A21A
−1
11 A12 =
1
f + gT
(
f + g
f
y2 − 2y
(
y + τ2h−
I∑
i=1
XiT
σ2i
)
+
[
w − `
2
T
]
+ 2y
(
y
T
+ τ2h−
I∑
i=1
XiT
σ2i
)
+
y2
T
(T − 1)
)
=
y2
fT
+
1
f + gT
(
w − `
2
T
)
Finally,
[(ZᵀV −1Z)−1](T+1),(T+1) =
(
`− z − y
2
fT
− 1
f + gT
(
w − `
2
T
))−1
=
fT (f + gT )
fT (f + gT )(`− z)− (f + gT )y2 − f(Tw − `2)
Web Appendix B
When ni = n, then σ
2
i = σ
2
e/n = σ
2 and we can express
f =
I
σ2 + τ2T
, g =
τ2I
σ2(σ2 + τ2T )
, ` =
U
σ2
w =
W
(σ2)2
, z =
τ2V
σ2(σ2 + τ2T )
, y =
U
σ2 + τ2T
where U , V and W are defined as in equation 8 of Hussey and Hughes (2007). Straightforward algebra yields
Var(θˆ) =
fT (f + gT )
fT (f + gT )(`− z)− (f + gT )y2 − f(Tw − `2)
=
Iσ2(σ2 + τ2T )
σ2(IU −W ) + τ2(ITU − IV − TW + U2)
which is the expression from equation 8 of Hussey and Hughes (2007).
Web Appendix C
Let v = (v1, · · · , vI) denote a permutation of n = (n1, · · · , nI). It’s understood that `, w, y, z are functions of v, but
the dependency is omitted for simplicity. The denominator of the treatment effect variance
D(v) = fT (f + gT )(`− z)− (f + gT )y2 − f(Tw − `2)
can be re-expressed in matrix notation as:
D(v) = fT (f + gT )(Bᵀ(Pα)− (B2)ᵀ(Pβ))− (f + gT )(Pγ)ᵀBBᵀ(Pγ)− f(Pα)ᵀ(TXXᵀ −BBᵀ)(Pα)
where
Bᵀ =
(
I∑
j=1
X1j ,
I∑
j=1
X2j , ...,
I∑
j=1
XIj
)
= (X1·, X2·, ..., XI·)
Hosted by The Berkeley Electronic Press
5(B2)ᵀ =
( I∑
j=1
X1j
)2
,
(
I∑
j=1
X2j
)2
, ...,
(
I∑
j=1
XIj
)2 = (X21·, X22·, ..., X2I·)
αᵀ =
(
1
σ21
,
1
σ22
, ...,
1
σ2I
)
βᵀ =
(
τ2
σ21(σ
2
1 + τ
2T )
,
τ2
σ22(σ
2
2 + τ
2T )
, · · · , τ
2
σ2I (σ
2
I + τ
2T )
)
γᵀ =
(
1
σ21 + τ
2T
,
1
σ22 + τ
2T
, · · · , 1
σ2I + τ
2T
)
where permutation matrix P ∈ {0, 1}I×I satisfies
I∑
i=1
Pij = 1 ∀j,
I∑
j=1
Pij = 1 ∀i
Note that the components of α, β, γ are ordered the same as n, and v = Pn uniquely. Therefore, we may proceed
with optimization over permutation matrices P and express the objective as D(P ). In order to feed the objective into
an optimization package, we need to reformulate the problem into a mixed-integer quadratic programming (MIQP)
problem, which requires decision variables in a vector, while our current form is a matrix. Therefore, we vectorize P .
To determine the vectorization, we expand the matrix operations:
Bᵀ(Pα)− (B2)ᵀ(Pβ) =
I∑
t=1
I∑
j=1
PtjXt·αj −
I∑
t=1
I∑
j=1
PtjX
2
t·βj =
I∑
t=1
I∑
j=1
Ptj(Xt·αj −X2t·βj)
(Pγ)ᵀBBᵀ(Pγ) =
I∑
i=1
I∑
j=1
γi(P
ᵀBBᵀP )i,jγj =
I∑
i=1
I∑
j=1
I∑
s=1
I∑
t=1
γiγj(BB
ᵀ)stPsiPtj
(Pα)ᵀ(TXXᵀ −BBᵀ)(Pα) =
I∑
i=1
I∑
j=1
αi(P
ᵀ(TXXᵀ −BBᵀ)P )i,jαj
=
I∑
i=1
I∑
j=1
I∑
s=1
I∑
t=1
αiαj(TXX
ᵀ −BBᵀ)stPsiPtj
The matrix M and vector D is the collection of the coefficients corresponding to the quadratic and linear sums,
respectively, which can be simplified into
M(s−1)I+i,(t−1)I+j = −(f + gT )
(
I∑
k=1
Xsk
)(
I∑
k=1
Xtk
)
1
(σ2i + τ
2T )(σ2j + τ
2T )
− f
[
T
I∑
k=1
XskXtk −
(
I∑
k=1
Xsk
)(
I∑
k=1
Xtk
)]
1
σ2i σ
2
j
and
D(t−1)I+j = fT (f + gT )
( I∑
k=1
Xtk
)
1
σ2j
−
(
I∑
k=1
Xtk
)2
τ2
σ2j (σ
2
j + τ
2T )

Web Appendix D
Let’s consider a treatment status matrix X, where q clusters are randomized at each step, there are b baseline
time-points and t time-points after each step, so the total number of time-points T = I
q
t+ b. Note that
P(Xi(b+pt+1) = 1) = · · · = P(Xi(b+(p+1)t) = 1) def= λp
https://biostats.bepress.com/harvardbiostat/paper216
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for all i, b, t, p. Indeed, for any cluster i, its treatment status at times {b+ pt+ 1, · · · , b+ (p+ 1)t} remain the same;
treatment status of a cluster can only change at each step, not at different time-points associated with the same step.
That is, Xi(b+pt+1) = · · · = Xi(b+(p+1)t). We observe the recursive relation
λp = P(Xi(b+(p+1)t) = 1|Xi(b+pt) = 1)P(Xi(b+pt) = 1) + P(Xi(b+(p+1)t) = 1|Xi(b+pt) = 0)P(Xi(b+pt) = 0)
= 1 · λp−1 + q
I − pq (1− λp−1)
with initial condition λ−1 = 0, since no cluster is randomized to treatment initiation before time b + 1. Through
techniques from difference equations (or simply by inspection), we see that
λp =
(p+ 1)q
I
solves the recurrence relation. In general, for k = 1, · · · , T ,
P(Xik = 1) =
d k−b
t
eq
I
Now let’s derive the joint distribution of (Xik, Xjl). Assume without loss of generality that k < l. Then,
P(Xik = Xjl = 1) = P(Xik = 1)P(Xjl = 1|Xik = 1) = d
k−b
t
eq
I
d l−b
t
eq − 1
I − 1
If k > l, the variables would change places, hence in general,
P(Xik = Xjl = 1) =
(d k−b
t
e ∧ d l−b
t
e)q
I
(d k−b
t
e ∨ d l−b
t
e)q − 1
I − 1
where a ∧ b = min(a, b) and a ∨ b = max(a, b). Now we may begin computing expectations. Starting with E(`),
E(`) = E
( I∑
i=1
T∑
j=1
Xij
σ2i
)
=
I∑
i=1
I/q−1∑
p=−1
1
σ2i
tE(Xi(b+(p+1)t))
=
I∑
i=1
I/q−1∑
p=−1
1
σ2i
t(p+ 1)
q
I
=
I∑
i=1
1
σ2i
t
q
I
I
q
(
I
q
+ 1
)
2
=
I∑
i=1
T − b+ t
2σ2i
=
T − b+ t
2
(f + gT )
Next for E(z):
E(z) = E
 I∑
i=1
τ2
σ2i (σ
2
i + Tτ
2)
(
T∑
j=1
Xij
)2
=
I∑
i=1
τ2
σ2i (σ
2
i + Tτ
2)
E
(
T∑
j=1
Xij
)2
Expanding the expectation,
E
(
T∑
j=1
Xij
)2
=
(
T∑
j=1
E(X2ij)
)
+
(
2
∑
k<l
E(XikXil)
)
=
T − b+ t
2
+ 2
T∑
k=1
d k−b
t
eq
I
(T − k)
=
T − b+ t
2
+ 2
I/q−1∑
p=−1
(p+ 1)
q
I
(
Tt− tb− t(t+ 1)
2
− pt2
)
=
T − b+ t
2
+ (T − b)(T − b+ t)− (t+ 1)(T − b+ t)
2
− (2T − 2b− 2t)(T − b+ t)
3
=
(T − b+ t)(2T − 2b+ t)
6
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7And therefore
E(z) = (T − b+ t)(2T − 2b+ t)
6
I∑
i=1
τ2
σ2i (σ
2
i + Tτ
2)
=
g(T − b+ t)(2T − 2b+ t)
6
Note that
f + gT =
I∑
i=1
1
σ2i
=
I∑
i=1
ni
σ2e
=
NSW
σ2e
where NSW =
I∑
i=1
ni and g =
1
T
(
NSW
σ2e
− f), so,
E(`− z) = T − b+ t
2
(
NSW
σ2e
− 1
3T
(
NSW
σ2e
− f
)
(2T − 2b+ t)
)
Let s1 =
I∑
i=1
1
(σ2i+Tτ
2)2
. Then for E(y2):
E(y2) = E
[( I∑
i=1
T∑
j=1
Xij
σ2i + Tτ
2
)2]
=
(T − b+ t)(2T − 2b+ t)
6
s1 +
∑
i6=i′
∑
j,j′ E(XijXi′j′)
(σ2i + Tτ
2)(σ2i′ + Tτ
2)
We may compute ∑
j<j′
E(XijXi′j′) =
T∑
j=1
(d j−b
t
e)q
I
T∑
j′=j+1
(d j′−b
t
e)q − 1
I − 1
For the innermost sum, we can break the summation range into portions corresponding to (1) Xi′j′ randomized at
the same time point as Xij , for which there are b +
⌈
j−b
t
⌉
t − j instances, and (2) Xi′j′ randomized to a time-point
subsequent to Xij , for which there are t instances. Therefore,
∑
j<j′
E(XijXi′j′) =
T∑
j=1
(d j−b
t
e)q
I
(b+ ⌈ j − b
t
⌉
t− j
) d j−b
t
eq − 1
I − 1 +
I/q−1∑
p′=d j−b
t
e
(p′ + 1)q − 1
I − 1 t

=
I/q−1∑
p=−1
(p+ 1)q
I
(p+ 1)q − 1
I − 1
(
t(t− 1)
2
)
+
I/q−1∑
p=−1
I/q−1∑
p′=p+1
(p+ 1)q
I
(p′ + 1)q − 1
I − 1 t
2
=
(t− 1)(T − b+ t)(2I + q − 3)
12(I − 1) +
(T − b+ t)(T − b− t)(3I + 2q − 4)
24(I − 1)
and
I∑
j=1
E(XijXi′j) =
I/q−1∑
p=−1
(p+ 1)q
I
(p+ 1)q − 1
I − 1 t =
(T − b+ t)(2I + q − 3)
6(I − 1)
so,∑
j,j′
E(XijXi′j′) =
(T − b+ t)(2I + q − 3)
6(I − 1) + 2
(
(t− 1)(T − b+ t)(2I + q − 3)
12(I − 1) +
(T − b+ t)(T − b− t)(3I + 2q − 4)
24(I − 1)
)
=
T − b+ t
12(I − 1) [(T − b)(3I − 4) + It− 2t+ 2qT − 2qb]
=
T − b+ t
12(I − 1) [(T − b)(3I − 4) + t(3I − 2)]
Finally,
E(y2) = (T − b+ t)(2T − 2b+ t)
6
s1 +
T − b+ t
12(I − 1) [(T − b)(3I − 4) + t(3I − 2)](f
2 − s1)
=
[
(T − b+ t)(T − b− t)I
12(I − 1)
]
s1 +
[
(T − b+ t)[3I(T − b+ t)− 2(2T − 2b+ t)]
12(I − 1)
]
f2
Next,
E(w) =
T∑
j=1
(
I∑
i=1
E(X2ij)
σ4i
+ 2
∑
i<i′
E(XijXi′j)
σ2i σ
2
i′
)
=
T − b+ t
2
I∑
i=1
1
σ4i
+
(T − b+ t)(2I + q − 3)
6(I − 1) 2
∑
i<i′
1
σ2i σ
2
i′
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=
1
σ4e
(
T − b+ t
2
(
I∑
i=1
n2i
)
+
(T − b+ t)(2I + q − 3)
6(I − 1)
(
2
∑
i<i′
nini′
))
and
E(`2) = (T − b+ t)(2T − 2b+ t)
6
I∑
i=1
1
σ4i
+
(T − b+ t)[3I(T − b+ t)− 2(2T − 2b+ t)]
12(I − 1) 2
∑
i<i′
1
σ2i σ
2
i′
=
1
σ4e
(
(T − b+ t)(2T − 2b+ t)
6
(
I∑
i=1
n2i
)
+
(T − b+ t)[3I(T − b+ t)− 2(2T − 2b+ t)]
12(I − 1)
(
2
∑
i<i′
nini′
))
with the derivation above following similar steps in the computation of E(y2). Hence,
E(Tw − `2) = T − b+ t
σ4e
(
Y1
(
I∑
i=1
n2i
)
+ Y2
(
2
∑
i<i′
nini′
))
where
Y1 =
T + 2b− t
6
and Y2 =
IT + 2qT − 2T + 3Ib− 4b− 3tI + 2t
12(I − 1)
Let κ denote the sample coefficient of variation (CV) for cluster sizes ni, we have:
κ2 =
1
I−1
I∑
i=1
(
ni − NSWI
)2
N2
SW
I2
⇐⇒
I∑
i=1
n2i =
N2SW
I
(
I − 1
I
κ2 + 1
)
we may substitute to yield
E(Tw − `2) = T − b+ t
σ4e
(
N2SW
I
(
I − 1
I
κ2 + 1
)
Y1 +
(
N2SW − N
2
SW
I
(
I − 1
I
κ2 + 1
))
Y2
)
=
(T − b+ t)N2SW
σ4e
(
(I − 1)(Y1 − Y2)
I2
κ2 + Y2 +
Y1 − Y2
I
)
=
(T − b+ t)N2SW
12(T − b)σ4e
(
(T + b)(T − b− t)
I
κ2 + T 2 + 2bT − tT − 3b2 + 3bt
)
Web Appendix E
In order to obtain variance formula similar to equation 8 in Hussey and Hughes (2007) that accounts for cluster size
variation, we approximated f and s1 by their first order Taylor expansion about the mean cluster size:
f =
I∑
i=1
1
σ2i + Tτ
2
=
I∑
i=1
ni
σ2e + niTτ2
≈
I∑
i=1
[ n
σ2e + (n)Tτ2
+
σ2e(ni − n)
(σ2e + (n)Tτ2)2
]
=
I
σ2e
n
+ Tτ2
s1 =
I∑
i=1
1
(σ2i + Tτ
2)2
=
I∑
i=1
n2i
(σ2e + niTτ2)2
≈
I∑
i=1
[ (n)2
(σ2e + (n)Tτ2)2
+
2(n)σ2e(ni − n)
(σ2e + (n)Tτ2)3
]
=
I(σ2e
n
+ Tτ2
)2
where n is the mean cluster size. Note that this approximation is exact if ni = n for all i; that is, cluster sizes do not
change. Substituting these approximations,
E(`− z) ≈ U
σ2
− τ
2V
σ2(σ2 + τ2T )
and E(y2) ≈
(
U
σ2 + τ2T
)2
where
U =
I(T − b+ t)
2
and V =
I(T − b+ t)(2T − 2b+ t)
6
We retain
E(Tw − `2) = (T − b+ t)N
2
SW
12(T − b)σ4e
(
(T + b)(T − b− t)
I
κ2 + T 2 + 2bT − tT − 3b2 + 3bt
)
to account for cluster size variation.
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9EP [Var(θˆ|P )] ≈ fT (f + gT )
fT (f + gT )E(`− z)− (f + gT )E(y2)− fE(Tw − `2)
≈ ITσ
2(σ2 + Tτ2)
σ2(ITU − U2 − I2C) + Tτ2(ITU − IV − I2C)
where
C =
(T − b+ t)
12(T − b)
(
(T + b)(T − b− t)
I
κ2 + T 2 + 2bT − tT − 3b2 + 3bt
)
Web Appendix F
Substituting, U = I(T − b+ t)/2 and V = I(T − b+ t)(2T − 2b+ t)/6 into the approximation from Appendix E,
EP [Var(θˆ|P )] ≈ ITσ
2(σ2 + Tτ2)
σ2
(
IT I(T−b+t)
2
−
(
I(T−b+t)
2
)2
− I2C
)
+ Tτ2
(
IT I(T−b+t)
2
− I I(T−b+t)(2T−2b+t)
6
− I2C
)
=
12(T − b)Tσ2(σ2 + Tτ2)
I(T − b+ t)(T − b− t)(σ2(2T − T+b
I
κ2) + Tτ2(T + b− T+b
I
κ2))
Let
ρ =
τ2
σ2e + τ2
, σ2t = σ
2
e + τ
2, n =
NSW
I
=⇒ τ2 = ρσ2t , σ2e = σ2t (1− ρ), σ2 = σ
2
e
n
=
σ2t (1− ρ)
n
And so
EP [Var(θˆ|P )] ≈ 12(T − b)T
σ2t (1−ρ)
n
(σ2t (1−ρ)
n
+ Tρσ2t
)
I(T − b+ t)(T − b− t)(σ2t (1−ρ)
n
(2T − T+b
I
κ2) + Tρσ2t (T + b− T+bI κ2)
)
=
12(T − b)Tσ2t (1− ρ)(1− ρ+ Tρn)
In(T − b+ t)(T − b− t)(T (2(1− ρ) + (T + b)nρ)− T+b
I
κ2(1− ρ+ Tnρ))
In an individually randomized trial with total sample size NSW = nI and two equally sized treatment groups of
size nI/2, the T-statistic under the alternative θA is T =
θA√
2σ2t /(nI/2)
= θA√
4σ2t /(nI)
with the variance of the treatment
effect 4σ2t /(nI). Therefore, the design effect for a cross-sectional SW-CRT with unequal cluster sizes is:
DEw,κ =
EP [Var(θˆ|P )]
4σ2t /(nI)
≈ 3(T − b)T (1− ρ)(1− ρ+ Tρn)
(T − b+ t)(T − b− t)(T (2(1− ρ) + (T + b)nρ)− T+b
I
κ2(1− ρ+ Tnρ))
Web Appendix G
When κ = 0, then DEw,κ reduces to
DEw =
3(T − b)(1− ρ)(1− ρ+ Tρn)
(T − b+ t)(T − b− t)(2(1− ρ) + (T + b)nρ)
https://biostats.bepress.com/harvardbiostat/paper216
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The design effect provided in Woertman et al. (2013) is
DEw =
[1 + ρ(Ktn+ bn− 1)]
[1 + ρ( 1
2
Ktn+ bn− 1)]
3(1− ρ)
2t
(
K − 1
K
)
where K = (T − b)/t is the number of steps. Indeed,
[1 + ρ(Ktn+ bn− 1)]
[1 + ρ( 1
2
Ktn+ bn− 1)]
3(1− ρ)
2t
(
K − 1
K
) = (1 + ρ(nT − 1))3(1− ρ)
(1 + ρ(n
2
(T + b)− 1))2t
(
T−b
t
− t
T−b
)
=
3(T − b)(1− ρ)(1− ρ+ Tρn)
(2(1− ρ) + nρ(T + b))((T − b)(T − b)− t2)
=
3(T − b)(1− ρ)(1− ρ+ Tρn)
(T − b+ t)(T − b− t)(2(1− ρ) + nρ(T + b))
Web Appendix H
The power is
1− β ≈ Φ
 θA√
EP [Var(θˆ|P )]
− z1−α/2

=⇒ θ
2
A
(z1−β + z1−α/2)2
≈ EP [Var(θˆ|P )] ≈ 12(T − b)Tσ
2
t (1− ρ)(1− ρ+ Tρn)
In(T − b+ t)(T − b− t)(T (2(1− ρ) + (T + b)nρ)− T+b
I
κ2(1− ρ+ Tnρ))
Solving for NSW
def
= In yields
NSW =
3(T − b)(1− ρ)(1− ρ+ Tρn)
(T − b+ t)(T − b− t)(2(1− ρ) + (T + b)nρ)
4σ2t (z1−β + z1−α/2)
2
θ2A
+
n(T + b)(1− ρ+ Tnρ)κ2
T (2(1− ρ) + (T + b)nρ)
=
3(T − b)(1− ρ)(1− ρ+ Tρn)
(T − b+ t)(T − b− t)(2(1− ρ) + (T + b)nρ)
4σ2t (z1−β + z1−α/2)
2
θ2A
+ nκ2
(
1− (T − b)(1− ρ)
T (2(1− ρ) + (T + b)nρ)
)
= DEwNind + CF
where DEw is the DE by Woertman et al. (2013), Nind is the sample size for an individually randomized trial, and
CF is the correction factor for cluster size variation.
Web Appendix I
RE ≈ DEw
DEw,κ
=
3(T−b)(1−ρ)(1−ρ+Tρn)
(T−b+t)(T−b−t)(2(1−ρ)+(T+b)nρ)
3(T−b)T (1−ρ)(1−ρ+Tρn)
(T−b+t)(T−b−t)(T (2(1−ρ)+(T+b)nρ)−T+b
I
κ2(1−ρ+Tnρ))
=
T (2(1− ρ) + (T + b)nρ)− T+b
I
κ2(1− ρ+ Tnρ)
T (2(1− ρ) + (T + b)nρ)
= 1−
T+b
I
κ2(1− ρ+ Tnρ)
T (2(1− ρ) + (T + b)nρ)
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= 1− κ
2
I
(
1− (T − b)(1− ρ)
T (2(1− ρ) + (T + b)nρ)
)
References
Hussey, M. A. and Hughes, J. P. (2007). Design and analysis of stepped wedge cluster
randomized trials. Contemp Clin Trials 28, 182–91.
Woertman, W., de Hoop, E., Moerbeek, M., Zuidema, S. U., Gerritsen, D. L., and Teerenstra,
S. (2013). Stepped wedge designs could reduce the required sample size in cluster
randomized trials. J Clin Epidemiol 66, 752–8.
https://biostats.bepress.com/harvardbiostat/paper216
